Benitec Biopharma Inc. (BNTC) Social Stream
BENITEC BIOPHARMA INC (BNTC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BNTC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-20 | 1 | $10 | $10 | $10 | $3.17 | 215.46% |
| 2022-10-18 | 1 | $4.001 | $4.001 | $4.001 | $3.17 | 26.21% |
| 2022-11-25 | 2 | $4.001 | $4 | $4 | $3.17 | 26.18% |
| 2023-05-18 | 1 | $68.027 | $68.027 | $68.027 | $3.17 | 2045.96% |
| 2023-09-26 | 1 | $6 | $6 | $6 | $3.17 | 89.27% |
The Trend in the Analyst Price Target
Over the past 131 days, BNTC's average price target has gone down $62.03.
Over the past 131 days, BNTC's average upside potential has been 12,150.8%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-18 | 1 | 4.000 | 4.000 | 4.000 | 0.197 | 1930.46% |
| 2023-05-18 | 1 | 68.027 | 68.027 | 68.027 | 0.197 | 34431.47% |
| 2023-09-26 | 1 | 6.000 | 6.000 | 6.000 | 3.150 | 90.48% |
BNTC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
BNTC's average broker recommendation rating improved by 0 over the prior 48 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BENITEC BIOPHARMA INC's number of analysts covering the stock is greater than 2.83% of them.
- To contextualize these metrics, consider that out of all US stocks, BENITEC BIOPHARMA INC's variance in analysts' estimates is lower than 96.31% of them.
- BNTC has a greater average analyst price target than 121.63% of Pharmaceutical Products stocks.
- BENITEC BIOPHARMA INC's upside potential (average analyst target price relative to current price) is higher than 192.74% of stocks in the nano market cap category.
In the Pharmaceutical Products industry, INM, PTPI, and GRI are the three stocks most similar to BENITEC BIOPHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BNTC? Use POWR Ratings for clearer insight into price direction.